Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3550-3555

  Kim, Sung Rae ^a   Yoo, Ji Han ^a   Song, Ho Cheol ^a   Lee, Seong Su ^a   Yoo, Soon Jib ^a   Kim, Young Du ^a   Lim, Yeon Soo ^a   Kim, Hyung Wook ^a   Yang, Chul Woo ^a   Kim, Yong Soo ^a   Choi, Euy Jin ^a   Kim, Yong Kyun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

adiposity; diabetes mellitus; glomerular filtration rate; obesity

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CLINICAL ASSESSMENT TOOL; COCKCROFT GAULT EQUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MODIFICATION OF DIET IN RENAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS ADIPOSITY; VISCERAL ADIPOSITY;

ADIPOSITY; BODY MASS INDEX; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INTRA-ABDOMINAL FAT; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROGNOSIS; RISK FACTORS; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80155192407     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq634     Document Type: Article

References (30)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
2. Iseki K. Chronic kidney disease in Japan. Intern Med 2008; 47: 681-689
3. Stengel B, Tarver-Carr ME, Powe NR et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479-487
4. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
5. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
6. Elsayed EF, Sarnak MJ, Tighiouart H et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008; 52: 29-38
7. Pinto-Sietsma SJ, Navis G, Janssen WM et al. PREVEND Study Group. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003; 41: 733-741
8. Ting SM, Nair H, Ching I et al. Overweight, obesity and chronic kidney disease. Nephron Clin Pract 2009; 112: C121-c127
9. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004; 79: 379-384
10. Rexrode KM, Carey VJ, Hennekens CH et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-1848
11. Poirier P, Després JP. Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil 2003; 23: 161-169
12. Hayashi T, Boyko EJ, Leonetti DL et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004; 140: 992-1000
13. Wajchenberg BL. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738
14. Mertens I, Van Gaal LF. Visceral fat as a determinant of fibrinolysis and hemostasis. Semin Vasc Med 2005; 5: 48-55
15. Miyazawa-Hoshimoto S, Takahashi K, Bujo H et al. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003; 46: 1483-1488
16. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48
17. Young JA, Hwang SJ, Sarnak MJ et al. Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol 2008; 3: 1786-1791
18. Iseki K. Predictors of diabetic end-stage renal disease in Japan. Nephrology (Carlton) 200510 Suppl): S2-S6
19. Shankar A, Leng C, Chia KS et al. Association between body mass index and chronic kidney disease in men and women: Populationbased study of Malay adults in Singapore. Nephrol Dial Transplant 2008; 23: 1910-1918
20. Gallagher D, Kelley DE, Yim JE et al. MRI Ancillary Study Group of the Look AHEAD Research Group. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89: 807-814
21. Ferland M, Despres JP, Tremblay A et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements. Br J Nutr 1989; 61: 139-148
22. Tirkes AT, Gottlieb RH, Voci SL et al. Risk of significant coronary artery disease as determined by CT measurement of the distribution of abdominal adipose tissue. J Comput Assist Tomogr 2002; 26: 210-215
23. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diab Care 1997; 20: 1087-1092
24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
25. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
26. Goodpaster BH, Krishnaswami S, Resnick H et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diab Care 2003; 26: 372-379
27. Gastaldelli A, Miyazaki Y, Pettiti M et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002; 87: 5098-5103
28. Mandavilli A, Cyranoski D. Asia's big problem. Nat Med 2004; 10: 325-327
29. Park YW, Allison DB, Heymsfield SB et al. Larger amounts of visceral adipose tissue in Asian Americans. Obes Res 2001; 9: 381-387
30. Kang YS, Han KH, Han SY et al. Characteristics of population with normal serum creatinine impaired renal function and: The validation of a MDRD formula in a healthy general population. Clin Nephrol 2005; 63: 258-266